Bicycle Therapeutics Plc Adr stock is traded at $3.52, with a volume of 52,537. It is up +1.15% in the last 24 hours and down -7.12% over the past month. Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Previous Close:
$3.48
Open:
$3.50
24h Volume:
52,537
Relative Volume:
0.14
Market Cap:
$246.73M
Revenue:
$63.39M
Net Income/Loss:
-$219.51M
P/E Ratio:
-
EPS:
-$3.16
Net Cash Flow:
-$231.83M
1W Performance:
-3.83%
1M Performance:
-7.12%
6M Performance:
-31.65%
1Y Performance:
-45.93%
1-Day Range:
$3.49$3.57
1-Week Range:
$3.47$3.80
52-Week Range:
$3.33$7.83
Bicycle Therapeutics Plc Adr Stock (BCYC) Company Profile
Name
Bicycle Therapeutics Plc AdrSector
HealthcareIndustry
BiotechnologyPhone
011441223261503Address
BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE, United KingdomMarket Cap
Revenue
Net Income
Cash Flow
EPS